MAPT and Cognitive impairment: Notably however, the PLB4 hBACE1 AD mouse model displays memory impairments at 6 months of age, despite the lack of overt tau pathology within the brain [21], therefore suggesting that the hBACE1 knock-in and metabolic dysfunction may have a role in influencing the cognitive deficits observed.